Anticoagulation With Dabigatran: When to Worry
Publication Date / Copyright Date
Dabigatran etexilate is the prodrug of dabigatran, a direct thrombin inhibitor that is used to reduce the risk for stroke and systemic embolism in patients with nonvalvular atrial fibrillation (NVAF) and to prevent and treat venous thromboembolism (VTE).
Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences
anticoagulation, dabigatran, embolism, inhibitor, nonvalvular atrial fibrillation (NVAF) stroke
Singh-Franco, Devada, "Anticoagulation With Dabigatran: When to Worry" (2015). Faculty Articles. 371.